No Prescription |
 |
 | ||
|
Nilstat Mycostatin |
|
| ||
No Prescription » Prescription Drugs 12 » Nilstat Mycostatin Nystatin is used to treat fungal infections of the skin mouth vagina and intestinal tract. Fungal medicines will not work for colds flu or other viral infections.Nystatin comes as a tablet and a liquid to take by mouth; a soft lozenge (pastille) to be dissolved slowly in the mouth; a tablet and vaginal cream to be inserted into the vagina; and in powder ointment and cream to be applied to the skin.Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take nystatin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Allow the lozenges (pastilles) to dissolve slowly in your mouth. Do not chew or swallow lozenges whole. Continue to use nystatin lozenges (pastilles) for at least 48 hours after symptoms of your mouth infection disappear.Nystatin liquid usually is used three to five times a day for mouth infections and three times a day for intestinal infections. Shake the bottle well before each use to mix the medication evenly. If you are using liquid nystatin for a mouth infection place half of the dose in each side of the mouth and hold it there or swish it throughout the mouth for several minutes before swallowing. Good oral hygiene including proper care of dentures is important for the cure of mouth infections.If you are using liquid nystatin for an intestinal infection just swallow the liquid you measured from the dropper; there is no need to hold it or swish it in your mouth.Nystatin skin ointment or cream usually is used several times a day for skin infections. Wash the affected area thoroughly. Apply a small amount of cream or ointment and gently and thoroughly massage it into your skin. If you use this medication on your face keep it out of your eyes. Buy Nilstat Mycostatin and other Prescription Drugs 12 products online at Medstore. 198
About Nilstat Mycostatin: Product Type: Prescription Drugs 12 Nilstat ( Mycostatin Nystop Pedi-Cri Generic Nystatin ) Nilstat (Mycostatin Nystop Pedi-Cri Generic Nystatin) Mycostatin Nystop Pedi-Cri Generic Nystatin 500 000u 50 caps Mycostatin Nystop Pedi-Cri Generic Nystatin Nilstat
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
